Volume 2, Issue 2 (2017)
IJMPP 2017, 2(2): 239-243 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hatami H, Bahrainian M, Mustafa Zadeh B, Mirfakhraei S, Kheradmand M A, Mirfakhraei M. The Prevalence Rate of Comorbidities (Psychiatric Disorders, Liver and Neuromuscular Pains Diseases) in Patients with Substance Abuse Referred to Borzouyeh clinic in 2010-2016. IJMPP 2017; 2 (2) :239-243
URL: http://ijmpp.modares.ac.ir/article-32-5440-en.html
URL: http://ijmpp.modares.ac.ir/article-32-5440-en.html
Hossein Hatami1 
, Mohammad Bahrainian1 , Babak Mustafa Zadeh1 , Shahla Mirfakhraei * 2, Mohammad Ali Kheradmand2 , Maryam Mirfakhraei3
, Mohammad Bahrainian1 , Babak Mustafa Zadeh1 , Shahla Mirfakhraei * 2, Mohammad Ali Kheradmand2 , Maryam Mirfakhraei3
1- Deparment of Public Health, School of public health and Environmental and Occupational Hazards Control Research Center, Shahid Behrshti University of Medical Sciences, Tehran, Iran.
2- School of public health and Environmental and Occupational Hazards Control Research Center,Shahid Behrshti University of Medical Sciences, Tehran, Iran.
3- Karaj Payam Noor University, Karaj, Iran.
2- School of public health and Environmental and Occupational Hazards Control Research Center,Shahid Behrshti University of Medical Sciences, Tehran, Iran.
3- Karaj Payam Noor University, Karaj, Iran.
Abstract: (5443 Views)
Background: Addiction is considered as a social disease causes economic loss in family shared financial resources, increase in health care costs, and sexual dysfunctions in sexual relations. Due to the high prevalence rate and reduced age of addiction beginning, this study aimed to evaluate the prevalence rate of comorbidities (psychiatric disorders, liver and neuromuscular diseases) in patients with substance abuse problems.
Methods and Material: In this descriptive study, 200 drug abusers referred to Borzouyeh clinic in Tehran, Iran were selected by convenience sampling method. Data were collected with the help of a questionnaire, liver function tests, and clinical records of the patients during 2010-2016. Data were analyzed through the analysis of Chi-square test at the significance level of P < .05.
Results: Data analysis was performed using chi-square test in SPSS software version 23. The results showed that there was a significant relationship between addiction and liver diseases, psychiatric disorders, and neuromuscular pains (p < .05). According to the results, 44.9% of the patients consuming crack had psychiatric disorders, and also 49.1% of the patients consuming opium had liver diseases. Also, neuromuscular pains were found in drug users (opium, sap, heroin and crack) and not found in hallucinogenic and stimulant drug users.
Conclusions: The correlations between opium and liver diseases, drug users and neuromuscular pains, and also crack using and psychiatric disorders were determined.
Methods and Material: In this descriptive study, 200 drug abusers referred to Borzouyeh clinic in Tehran, Iran were selected by convenience sampling method. Data were collected with the help of a questionnaire, liver function tests, and clinical records of the patients during 2010-2016. Data were analyzed through the analysis of Chi-square test at the significance level of P < .05.
Results: Data analysis was performed using chi-square test in SPSS software version 23. The results showed that there was a significant relationship between addiction and liver diseases, psychiatric disorders, and neuromuscular pains (p < .05). According to the results, 44.9% of the patients consuming crack had psychiatric disorders, and also 49.1% of the patients consuming opium had liver diseases. Also, neuromuscular pains were found in drug users (opium, sap, heroin and crack) and not found in hallucinogenic and stimulant drug users.
Conclusions: The correlations between opium and liver diseases, drug users and neuromuscular pains, and also crack using and psychiatric disorders were determined.
Subject:
Musculoskeletal Pain Prevention
Received: 2017/04/15 | Accepted: 2017/06/1 | Published: 2017/06/18
Received: 2017/04/15 | Accepted: 2017/06/1 | Published: 2017/06/18
References
1. American Society for Addiction Medicine (ASAM). (2012) Definition of addiction. Available from: .http://www.asam. org/for-the-public/definition-of-addiction.[Accessed on December 19, 2012].
2. ASAM releases new definition of addiction. (2012) http:// www.eurekalert.org/pub_releases/2011-08/asoa-arn072111. php.Last retrieved 31 December 2012.
3. National Institute on Drug Abuse (NIH). (2015) Advancing addiction sciences, Available from: https://www.drugabuse .gov/related-topics/trends-statistics [Accessed on July 8, 2017].
4. Fischer, B. & Rehm, J. (1996) the case for a heroin substitution treatment trial in Canada. Canadian Journal of Public Health. 88 (6), 367-370. [DOI:10.1007/BF03403907]
5. Hannesdottir, H., Tyrfingsson, T. & Piha, J. (2001) Psychosocial functioning and psychiatric comorbidity among substance-abusing Icelandic adolescents. Nordic Journal of Psychiatry, 55 (1), 43-8. [DOI:10.1080/080394801750093742]
6. Heidari Pahlavian, A., Mahjoub, H. & Rahimi, A. (2011) Mental disorders in substance dependent individuals as compared to non-substance dependent people in Hamadan, Iran. Journal of Hamadan University of Medical Sciences, 18 (3), 22-28.
7. Miller, M. ed (2013) Principles of addiction, comprehensive addictive behaviors and disorders. Elsevier Inc., 1, 23. eBook ISBN: 9780123983619, Available from: https://www.elsevier .com/books/principles-of-addiction/miller/978-0-12-398336-7 [Accessed on July 8, 2017].
8. Sadock, B. J. & Sadock, V. A. (2005) Kaplan and sadock's comprehensive textbook of psychiatry. 8th ed. New York: Lippincott Williams and Wilkins.
9. Sadock, B. J. & Sadock, V. A. (2007) Kaplan and Sadock's synopsis of psychiatry. 10th ed. Philadelphia: Williams and Wilkins.
10. Shavakhi, A., Sadeghi, A. R & Minakary, M. (2010) Opium consumption and risk of liver fibrosis in chronic Hepatitis B and C. Journal of Isfahan Medical School. 28 (110), 451-458.
11. Saisan, J., Melinda, S. & Jeanne, S. (2013) Substance abuse and mental health: overcoming alcohol abuse and drug addiction while coping with depression or anxiety. Available from: http://helpguide.org/mental/dual_diagnosis.htm[Accessed on July 8, 2017].
12. Hosseini, S. H., Zarghami, M., Moosavi, S. A., Nateghi G. R. & Masoudzadeh, A (2008). Study on the simultaneity of the substance abuse with psychiatric disorder in referred to outpatients to psychiatryclinic of Zare, sari, Iran Journal of Mazandaran University of Medical Sciences. 18 (67), 67-74.
13. Tazviri, A., Pasini, A., Saracco, M. & Spalletta, G. (1998) Psychiatric symptoms in male cannabis users not user illicit drugs. Addiction. 93 (4), 487-92. [DOI:10.1046/j.1360-0443.1998.9344874.x]
14. Vafaiee, B. & Parandavar, M. (2004) The role of physical illness in substance abuse. Journal of Sabzevar University of Medical Sciences. 11 (2), 60-66.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |